• Home
  • News
  • Coins2Day 500
  • Tech
  • Finance
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
HealthPfizer

Pfizer wants you to call its COVID vaccine Comirnaty. How the name came about

By
Chris Morris
Chris Morris
Former Contributing Writer
Down Arrow Button Icon
By
Chris Morris
Chris Morris
Former Contributing Writer
Down Arrow Button Icon
August 23, 2021, 12:12 PM ET

Fresh off its full approval by the FDA, the Pfizer COVID-19 vaccine (also referred to as the Pfizer-BioNTech vaccine) would now like to be known as Comirnaty.  

It’s a request with which few people are likely to comply.

The brand name for the Pfizer vaccine is a mouthful, but it’s not new. In fact, it has been around since last December. (There’s even a name for the generic version of the drug, whenever that hits the market: tozinameran.) But where did it come from?

Comirnaty (pronounced “koe-mir-na-tee”) is actually a car wreck of several words, all of which are centered around the pandemic and the breakthrough technology that enabled scientists to develop a vaccine so fast.

“Comirnaty…represents a combination of the terms COVID-19, mRNA, community, and immunity, to highlight the first authorization of a messenger RNA (mRNA) vaccine, as well as the joint global efforts that made this achievement possible,” said Pfizer in announcing EU authorization last year.

The name, which you might guess if you say it out loud, is meant to evoke community (even if it sounds like it’s being said by the woman in the “Ermahgerd” meme).

To break it down more, “Co” comes from COVID-19. “Mirna” is an adulterated version of mRNA. And “-ty” blends in the community and immunity themes.

As for that generic name, which is even more of a mouthful, “tozina-“ is a prefix required by the World Health Organization, while “meran” is a required suffix for mRNA vaccines.

If you’re not a fan of Comirnaty, it could have been…well, better or worse. You decide. Among the reported rejected names Pfizer and BioNTech considered were Covuity, RnaxCovi, Kovimerna, and RNXtract.

As for Moderna’s COVID vaccine? It doesn’t have a name in the U.S. Yet, but the odds-on favorite is Spikevax. The European Medicines Agency approved that name last month. When and if the FDA gives Moderna’s treatment full approval, it will rule on the name as well.

More health care and Big Pharma coverage from Coins2Day:

  • The most common COVID Delta variant symptoms in adults and kids
  • Google Health chief leaves to become CEO of health tech company Cerner
  • South Dakota sees the country’s largest two-week COVID surge
  • What side effects can you expect from the COVID-19 vaccine booster shots?
  • New U.S. COVID cases are up 52%. See where cases are rising the fastest

Subscribe to Coins2Day Daily to get essential business stories straight to your inbox each morning.

About the Author
By Chris MorrisFormer Contributing Writer

Chris Morris is a former contributing writer at Coins2Day, covering everything from general business news to the video game and theme park industries.

See full bioRight Arrow Button Icon
Rankings
  • 100 Best Companies
  • Coins2Day 500
  • Global 500
  • Coins2Day 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Coins2Day Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Coins2Day Brand Studio
  • Coins2Day Analytics
  • Coins2Day Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Coins2Day
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.